Experimental and clinical studies clearly demonstrate that increased glucose levels and impaired insulin signaling are potent drivers of the atherosclerotic process, even in the absence of concomitant risk factors such as hypertension, obesity, and dyslipidaemia (34). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.